In addition, the combination of ribavirin and IFN-α in chronic HBV treatment was reported to induce the proliferation of CD4+ T cells that produce various signalling cytokines to initiate antiviral actions in infected cells and to alert neighbouring cells of the threatening virus infection [73]. The gene discussed is IFNA1; the disease is viral infectious disease.